Insights into Treatment-Free Remission (TFR) outcomes in Chronic Myeloid Leukaemia (CML) - a tertiary centre experience in Malaysia.

Blood Res · 2025 · PMC12738440 · PMID 41423591

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

This is particularly relevant in the nilotinib-treated subgroup, with 6 out of 7 patients remaining in remission at the time of writing, suggesting a possible trend in favour of the second-generation TKI.

also in 888 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.